Stock Events

Stock Events

enGene Therapeutics (ENGN) Q3 2025 Earnings

11SepConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.57

-0.5

-0.42

-0.35

Details

Expected EPS

-0.497993

Actual EPS

-0.57

Surprise EPS

-0.07

Surprise Percent

+14.46%

Description

enGene Therapeutics (ENGN) has reported earnings of -0.57 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.